KMDA
Companies
NASDAQ
Kamada Ltd.
Health Care
$7.23
+$1.30 (+21.96%)
Price Chart
Overview
About KMDA
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Market Cap
$290.8M
Volume
697.8K
Avg. Volume
594.1K
P/E Ratio
22.16129
Dividend Yield
0.00%
Employees
305.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Risk & Correlation Analysis
Market Correlation
0.65
Low Correlation
Volatility
High (0.42)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KMDA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$290.8M
Volume697.8K
P/E Ratio22.16
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025